entity

pathological tau

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about pathological tau: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9Connections

2Hypotheses

5Analyses

3Outgoing

6Incoming

0Experiments

6Debates

No AI portrait yet

Outgoing (3)

Target	Relation	Type	Str
Neurodegeneration	biomarker_for	process	0.90
nucleocytoplasmic transport	inhibits	process	0.70
cGAS-STING signaling	activates	pathway	0.70

Incoming (6)

Source	Relation	Type	Str
25172552	catalyzes	paper	0.90
autophagy pathway	clearance_mechanism_for	pathway	0.70
conformational antibodies	associated_with	drug	0.70
FKBP52	associated_with	protein	0.70
TFEB	prevents	protein	0.70
lysosomal biogenesis	prevents	process	0.70

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Selective p38γ MAPK Inhibition Reduces Pathological Tau Phos	0.625	neurodegeneration	Test
O-GlcNAcylation at T212 competes with phosphorylation to red	0.380	alzheimers-disease-and-related-tauopathies	How can ESCRT or SNARE targeting achieve

Mentioning Analyses (5)

Scientific analyses that reference this entity

How can ESCRT or SNARE targeting achieve tau-specific effects without disrupting

molecular biology | 2026-04-08 | 8 hypotheses Top: 0.380

What is the therapeutic window between tau propagation inhibition and essential

neurodegeneration | 2026-04-06 | 5 hypotheses Top: 0.780

Tau propagation mechanisms and therapeutic interception points

neurodegeneration | 2026-04-04 | 18 hypotheses Top: 0.814

Gap 006 analysis (archived stub)

neurodegeneration | 2026-04-02 | 7 hypotheses Top: 0.760

Extracellular vesicle biomarkers for early AD detection

neurodegeneration | 2026-04-02 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (6)

Multi-agent debates referencing this entity

Analysis for knowledge gap 006 in the neurodegeneration domain.

closed · Rounds: 4 · Score: 0.79 · 2026-04-22

The debate highlighted that most promising targets (VAMP2, ESCRT, fascin-1) are

closed · Rounds: 4 · Score: 0.75 · 2026-04-22

Investigate prion-like spreading of tau pathology through connected brain region

closed · Rounds: 4 · Score: 0.90 · 2026-04-12

The debate identified fundamental druggability challenges for these targets due

closed · Rounds: 4 · Score: 0.95 · 2026-04-09

Tau propagation mechanisms and therapeutic interception points

closed · Rounds: 3 · Score: 0.95 · 2026-04-04

Extracellular vesicle biomarkers for early AD detection

closed · Rounds: 4 · Score: 0.87 · 2026-04-02

Related Research

Hypotheses and analyses mentioning pathological tau in their description or question text

No additional research found